# High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure

> **NCT03102827** · PHASE3 · TERMINATED · sponsor: **Heart and Diabetes Center North-Rhine Westfalia** · enrollment: 14 (actual)

## Conditions studied

- Heart Failure，Congestive

## Interventions

- **DRUG:** Oxygen
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03102827
- **Lead sponsor:** Heart and Diabetes Center North-Rhine Westfalia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-02
- **Primary completion:** 2018-03-27
- **Final completion:** 2018-03-27
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Unavailability of PI and Deputy
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03102827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03102827, "High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03102827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*